Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue - Wikidata - wikimedia - TriplyDB

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

http://www.wikidata.org/entity/Q34203924

about

DNA methylation screening identifies driver epigenetic events of cancer cell survival Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?Genetic and Epigenetic Alterations in Bladder Cancer The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood Context Sensitive Modeling of Cancer Drug Sensitivity Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.Developmental genes targeted for epigenetic variation between twin-twin transfusion syndrome children.A global profile of gene promoter methylation in treatment-naïve urothelial cancer Statistical approaches for the analysis of DNA methylation microarray data A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation Genomic insights into cancer-associated aberrant CpG island hypermethylation Epigenetic inactivation of ST6GAL1 in human bladder cancer.Diagnostic markers of urothelial cancer based on DNA methylation analysis.CHST11 gene expression and DNA methylation in breast cancer Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer.In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta.Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.Epigenetic alterations in bladder cancer and their potential clinical implications.Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer Identification of an epigenetic profile classifier that is associated with survival in head and neck cancer.Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.DNA methylation as clinically useful biomarkers-light at the end of the tunnel Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.Manipulating the epigenome for the treatment of urological malignancies.Global epigenetic profiling in bladder cancer.Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.DNA methylation-based biomarkers in bladder cancer.Alterations of DNA methylome in human bladder cancer.

P2860

Q24632287-383CAB07-F472-4A11-9BEC-5CDF0DCDFA8F Q26744146-93089807-0835-4FF0-9DE7-5C2F3E75A7F1 Q28074732-F49CE262-0D12-4C0C-9817-E1054446B137 Q28391041-9AEA86CC-B2DB-4E37-AD99-84DBEA229FA9 Q28547285-6EB6728F-4D72-4D84-BC52-AA4D4D2208AD Q31058055-BF88C6B6-66BE-441C-9BA8-AB590D6B5DEC Q33590312-40B5FFAC-7CC4-4E98-8782-320DF169C4A2 Q33779194-74D8088D-2097-4029-B6F1-1036D17DF50E Q33881906-D8A7F9B1-FABC-442C-A9A8-17108B6604C7 Q34091387-7253D8E7-99F0-4950-8785-222CD1C66D42 Q34227727-AB6FA958-E6DF-49FC-8B07-28AFC9BC4F5D Q34294336-3986BF9B-537A-44A2-920F-DD827CD9181A Q34441297-B4B02240-E17A-486E-83F7-77B1F13477BA Q34647477-A80F5FC3-2087-4600-8FAE-4E2CE0FD2349 Q34695132-CA43438D-242C-4542-B4B1-FB13BACE0F9E Q34756518-DF5004F0-50AB-43BF-AF7A-8A03E88E85A9 Q35073326-80907336-2395-4F15-82A1-D5A31AC40FCA Q35093755-1A571379-5776-49A2-A042-74668C5BDF6A Q35147519-A922364C-E9B4-420E-AA48-C4408FE7508B Q35215704-DFFBB821-7B02-4B61-B62C-4A6E1C1FF480 Q35389349-03A93AAE-2DB3-4B26-98FF-E339B7CFF311 Q35685060-03FE73E7-E731-430F-B3FA-2B5789253DBC Q35756857-848D2A86-9777-4BBF-BEE3-FFAD39375BC8 Q35762587-71877B32-279F-4CC3-86F9-55C66727C2B4 Q36095721-1DC55B26-944D-42B6-AF57-BD1419BA6AEF Q36097752-87D75FD6-A019-4B17-BAC2-B762E16DA027 Q36187834-13CCBB90-B43B-4274-B830-E76275C13EF6 Q36414395-7EB942ED-E4A6-4631-8121-4703E4D1A5F8 Q36730582-79558942-58EB-4035-81A8-79669C6DEE50 Q36833387-C092ECD9-D9E5-4BC2-830D-C23471FBEC60 Q36862682-C1066504-265B-4BDF-9F1D-420375A77F0C Q37148677-177142A3-B293-499C-8442-CB09A1246724 Q37374917-F3BC9166-E353-4E76-824B-535E704EF4F7 Q37524412-7B18E3B7-96F9-4D07-B9AB-0D501FDE8A7A Q37962571-68AE9006-2043-419A-B4CF-DBAB87BC81C1 Q37970466-1EA5DB7B-2DB2-44B0-88D5-294EA28BE11F Q37978544-F98D891F-3991-4BC5-AC07-93E536831F3F Q38068225-E8A2EEAF-1764-42AF-988E-A9D506DE59C0 Q38102879-487C0C16-3F0D-45D3-8EA3-F6C446D485A4 Q38131409-2B7FFE11-61FC-4BBA-A21E-E312EC38A328

P2860

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

http://www.wikidata.org/entity/Q34203924

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Unique DNA methylation pattern ...... defect in premalignant tissue

@ast

Unique DNA methylation pattern ...... defect in premalignant tissue

@en

Unique DNA methylation pattern ...... defect in premalignant tissue

@nl

type

label

Unique DNA methylation pattern ...... defect in premalignant tissue

@ast

Unique DNA methylation pattern ...... defect in premalignant tissue

@en

Unique DNA methylation pattern ...... defect in premalignant tissue

@nl

prefLabel

Unique DNA methylation pattern ...... defect in premalignant tissue

@ast

Unique DNA methylation pattern ...... defect in premalignant tissue

@en

Unique DNA methylation pattern ...... defect in premalignant tissue

@nl

P1433

Q34203924-E3DF7E72-3257-4CEE-9441-8AC47E6408CE

P1476

Q34203924-E7A7F799-5764-4C85-9C43-FC973A3FE6F2

P2093

Q34203924-274F8A01-6DC1-4068-B372-F3C484887F61

Q34203924-667E3A4D-D438-4DA1-BFA0-4563F2C32B16

Q34203924-6DE7C46A-9E1C-47DF-80DB-BED8E552017A

Q34203924-90A1A270-3E3C-4F4B-AC1A-260906F52B1A

Q34203924-9D03596F-7F71-4947-BA27-B18AD9B14651

Q34203924-9F9F64A4-C88B-41B7-B752-C3520D3F98BA

Q34203924-C34A03B6-2C6F-4DAF-A892-2A721631132A

Q34203924-E82C8630-48E5-4871-95BF-CAEF2B6E2631

Q34203924-F427A5B0-F2A3-41E5-BCDF-2765C5C1C506

P2860

Q34203924-05C64CD4-31C5-461A-B1F8-6875AE9D7481

Q34203924-1068C96D-E3BE-4C3F-8CFE-3AC349F8B886

Q34203924-117822FD-843D-48A1-A9D2-81C06AB22ED6

Q34203924-143A6C8D-3823-4172-9B1C-1F5F34C7BB2E

Q34203924-1BC8CE75-D35E-4364-9211-D9F964D125DF

Q34203924-20A0EEA8-2CE4-4E64-9BCA-08DAE19CFBCC

Q34203924-2B467F69-730A-4A3D-B294-422B0007FDBA

Q34203924-3D9C9C27-AE37-4D2A-ACC4-7127AC82470B

Q34203924-41F15CC9-178C-4DAE-81C6-87807283BF2A

Q34203924-459C68EC-46D5-4739-AD35-D4411FD7498A

P304

Q34203924-A1227A47-34BA-445E-B1A6-B34250A0B13F

P31

Q34203924-F102B489-E405-4EF1-9372-ADED07A06C4D

P356

Q34203924-6D07B10B-3478-4CB3-8166-5E5AE0E51F38

P407

Q34203924-8153AEAD-E1EA-4C13-99C6-DD5F97DED522

P433

Q34203924-D4427259-6782-4F59-BEC7-D91F70410CC9

P478

Q34203924-9C58F0E3-64DC-49DE-8061-0AEF55BB4926

P50

Q34203924-3DD394B5-179C-4501-BEF0-D406DC55AE9E

P577

Q34203924-52447054-DB4A-4319-B7EC-A71E23D67304

P5875

Q34203924-726141C1-3F9E-4A27-98A3-96CD7DFA3CA5

P698

Q34203924-7C8C29A8-66F4-499A-91E5-C19596BC1280

P921

Q34203924-1ED8A241-D3C3-4CD6-BE08-3F34AC67B3F0

P932

Q34203924-93317DA0-85E1-44FC-8645-4B65421D91F8

P356

0008-5472.CAN-10-1335

P1433

Cancer Research

P1476

Unique DNA methylation pattern ...... defect in premalignant tissue

@en

P2093

Daniel J Weisenberger

http://www.w3.org/2001/XMLSchema#string

Erika M Wolff

http://www.w3.org/2001/XMLSchema#string

Fei Pan

http://www.w3.org/2001/XMLSchema#string

Kimberly D Siegmund

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Kawashima

http://www.w3.org/2001/XMLSchema#string

Kokichi Sugano

http://www.w3.org/2001/XMLSchema#string

Peter A Jones

http://www.w3.org/2001/XMLSchema#string

Peter W Laird

http://www.w3.org/2001/XMLSchema#string

Yoshitomo Chihara

http://www.w3.org/2001/XMLSchema#string

P2860

The Sequence of the Human Genome

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

DNA methylation profiling of human chromosomes 6, 20 and 22

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

5-methylcytosine, gene regulation, and cancer

Epigenetics in human disease and prospects for epigenetic therapy

Friends or foes - bipolar effects of the tumour stroma in cancer

Epigenetic stem cell signature in cancer

Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.

LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability

P304

8169-8178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-1335

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46273216

http://www.w3.org/2001/XMLSchema#string

P698

20841482

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

2955801

http://www.w3.org/2001/XMLSchema#string